Smartac International Holdings Limited Overview
Smartac International Holdings is a small, Hong Kong-headquartered, Cayman-incorporated investment holding company whose listing on the Hong Kong Main Board was cancelled in February 2023 after nearly two years of suspension for failing to demonstrate a sufficient level of operations under Listing Rule 13.24. Originally floated in 2002 as Asia Zirconium, then the largest zirconium-chemicals exporter in the PRC, the group pivoted over the following decade into mall-focused social CRM and IT services (Smartac), WeChat Pay merchant acquiring in Hong Kong (Haihai Limited), and finally an online-to-offline (O2O) commerce model selling licensed beauty, wellness and fashion brands across Hong Kong and PRC e-commerce platforms. The business never achieved sustained profitability: it posted losses in every year from FY2018 to FY2021, revenue collapsed 73.9% in FY2021 after a supply-chain-trading spike in FY2020, and audit qualifications over receivables and inventory preceded the delisting. It is best characterised today as a delisted micro-cap shell-like holding company with residual trading operations.
Company's own description (latest annual report, FY2021)
According to the FY2021 Annual Report, the company is an investment holding company whose subsidiaries operate in three areas: (i) online-to-offline (O2O) commerce; (ii) electronic payment solutions; and (iii) "others", namely IT system development and support services. Within O2O commerce, management described three activities: commerce solutions for authorised brands spanning online and offline channels; e-tailing solutions for the sale and distribution of branded goods; and customised supply chain management solutions for enterprises. The electronic payment business, run through subsidiary Haihai Limited, provides WeChat Pay merchant access, settlement and marketing functions to Hong Kong merchants. The "others" segment provides tailor-made social CRM platforms and IT support, mainly to PRC shopping-mall operators, property managers and developers, using big-data analysis of consumer behaviour.
The final public update (30 December 2022) narrowed this to O2O commerce and electronic payment solutions, and disclosed new initiatives: sales of a Korean cosmetics brand in the PRC from November 2022 and a planned move into modular energy storage equipment.
Independent characterisation
In substance, the group by FY2020–FY2022 was a brand distributor and trading intermediary rather than a technology company. In FY2020, cost of sales was RMB 169.6 million against revenue of RMB 191.6 million (gross margin 11.5%), consistent with low-margin merchandise trading (supply chain solutions) rather than software or platform fees. The payments and CRM segments, the historic "technology" identity behind the Smartac name, together contributed only about 1.4% of revenue in FY2020 and about 10.2% in FY2021.
Revenue model mix
| Revenue type | Segment | Description | Approx. share FY2021 |
|---|---|---|---|
| Product sales (merchandise) | O2O commerce | Sale of branded beauty, wellness, apparel goods; supply chain trading | ~89.8% |
| Commission / transaction fees | Electronic payment solutions | Fees on WeChat Pay transaction value processed for HK merchants | ~4.9% |
| Service / project fees | Others | Social CRM platforms and IT support for PRC malls | ~5.3% |
| Subscription / licensing | — | No subscription or licensing revenue line disclosed | — |
Source: FY2021 AR segment disclosures; percentages computed from reported segment revenue.
Value chain position, customers, end-markets
Value chain position: Midstream distributor/retailer between overseas brand owners (UK, Israel, Korea, HK-listed supplement makers) and end consumers in Hong Kong and the PRC; also a reseller/agent for Tencent's WeChat Pay in Hong Kong.
Customer types: Retail consumers (HK pop-up stores, Tmall/JD.com flagship stores); enterprise buyers (supply chain solutions); HK merchants in medical/pharmaceutical services, cosmetics and beauty, jewellery, apparel, and food and beverage (payments); PRC mall operators and property developers (CRM).
Concentration: In FY2020 the largest customer was ~12.0% of revenue and the top five ~43.0%; the largest supplier ~18.6% of purchases and the top five ~43.1% (FY2020 AR).
End-markets: PRC cross-border and domestic e-commerce for beauty and health products; Hong Kong physical retail; Hong Kong mobile payments (inbound mainland tourist spending); PRC shopping-mall digital marketing.
Strategy
Stated strategic themes (paraphrased from FY2020–FY2021 Chairman's Statements and Dec 2022 update)
-
Integrated online-plus-offline one-stop solutions for quality overseas brands, aiming to build a base of high-value customers (FY2020).
-
Hong Kong as brand incubator, then PRC push — the Grace Cole model (HK pop-ups, then Tmall flagship), to be replicated for other international brands (FY2020).
-
Focus categories: health supplements and beauty products, citing heightened health awareness after COVID-19 (FY2020–FY2021).
-
Cost discipline and restructuring — disposing of loss-making subsidiaries, centralising warehousing, redeploying staff, chasing overdue receivables (FY2021).
-
WeChat Pay recovery on border reopening and helping merchants expand into the Greater Bay Area via WeChat ecosystem tools (FY2020–FY2021).
-
New verticals — PRC health food (Zhangzhou Keruilin), Korean cosmetics, and modular energy storage equipment (Dec 2022); possible wireless network equipment investment (FY2021).
Initiative register (last 24 months of public disclosure, 2021–2022)
| Date | Initiative | Status |
|---|---|---|
| Q2 2021 | Scale-down of supply chain solutions business | Executed |
| FY2021 | Consolidation of eight public warehouses into one self-managed central warehouse | Executed |
| 30 Sep 2021 | Exit from general merchandise trading (Upfront Success) | Completed |
| 4 Nov 2021 | MOU for health food JV | Superseded by JV agreement |
| 15/29 Nov 2021 | Health food JV (Zhangzhou Keruilin) formed, 60% | Completed |
| 3 Dec 2021 | Exit from Nutronic fertility-supplement JV (Smartronic) | Completed |
| 22 Feb 2022 | Keruilin made wholly owned (RMB 2M) | Completed |
| Nov 2022 | Korean cosmetics sales in the PRC; negotiating long-term supply deal | RMB 18.35M sales Nov–Dec 2022; long-term deal status unknown |
| Dec 2022 | Modular energy storage equipment | Announced intention only |
Guidance / medium-term targets
No quantitative financial targets or guidance were ever published. Management described itself as "cautiously optimistic" for 2022 (FY2021 AR). ESG commitments with targets: not disclosed.
Products & Services
O2O commerce
| Offering | Description | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|
| Grace Cole (UK bath and body) | Fragrant bath and body products; HK used as brand incubator for Southeast Asia, then PRC via Tmall | HK and PRC retail consumers | HK pop-ups Oct 2020; Tmall flagship Jan 2021 | Retail merchandise sales; not disclosed |
| Mimi Luzon (Israeli skincare) | Premium skincare via concept store in an HK department store; store intermittently closed under COVID measures | HK consumers | Oct 2020 | Retail; not disclosed |
| Stella McCartney (luxury fashion) | Franchise agreements to sell apparel and accessories in the PRC | PRC consumers | Mar 2020 | Franchise/merchandise; terms not disclosed |
| Nutronic fertility supplements (FertiCare, ConcepCare, NatalCare) | Exclusive PRC/HK distribution of male and female fertility supplements via Smartronic (51% owned) | PRC/HK consumers | Sep 2020; exited Dec 2021 with Smartronic disposal | Product purchase; annual caps RMB 3.9M (2020), RMB 6.4M (2021), RMB 6.4M (2022); actual 2020 purchases RMB 0.76M |
| Supply chain management solutions | Customised procurement/trading for enterprise clients | Enterprises | 2020; scaled down from Q2 2021 | Merchandise trading; low margin |
| General merchandise O2O trading | Online/offline general merchandise in PRC and HK via Upfront Success group | Consumers | Disposed 30 Sep 2021 | — |
| Health food (Zhangzhou Keruilin) | Marketing, promotion and sale of health food in the PRC | PRC consumers | Nov 2021; wholly owned Feb 2022 | — |
| Korean cosmetics brand (unnamed) | Sale of popular cosmetic products of a famous Korean brand in the PRC; ~RMB 18.35M sales Nov–Dec 2022 | PRC consumers / channels | Nov 2022 | Merchandise sales |
| WeChat merchant digital services | Set-up of WeChat official accounts, WeChat Malls and mini-programs for merchants, partly under HK Government Distance Business Programme | HK merchants | 2,020 | — |
Electronic payment solutions
| Offering | Description | Target customer | Launch / latest | Pricing |
|---|---|---|---|---|
| Haihai WeChat Pay acquiring | Payment access, settlement and marketing functions offered by WeChat Pay for HK merchants, online and offline | HK merchants serving mainland visitors and locals | Not disclosed; active through 2022 | Commission on transaction value (rates not disclosed) |
Others (IT services)
| Offering | Description | Target customer | Launch / latest | Pricing |
|---|---|---|---|---|
| Social CRM platform | Tailor-made social membership/CRM platforms using big data to understand shopper behaviour and personalise promotions | PRC shopping-mall operators, property managers, developers | Legacy Smartac product; revenue RMB 2.7M in FY2021 | Project/service fees; not disclosed |
| IT support services | System development and maintenance | Same | Ongoing to FY2021 | — |
Announced but not evidenced as launched
-
Modular energy storage equipment and related products (stated plan, 30 Dec 2022 announcement). No revenue, product specification or launch date disclosed.
-
Wireless network equipment investment (mentioned as a possibility in the FY2021 Chairman's Statement).
Legacy (pre-pivot) products — historical only
Zirconium oxychloride, zirconium carbonate, zirconium oxides and other zirconium chemicals; electrode materials for NiMH/NiCd rechargeable batteries; electronic ceramics (PTC heating components, zirconium tiles); nanometric zirconium oxide and cerium-zirconium compound — all under the "Long Jing" trademark (Asia Zirconium AR 2003–2006).
Financial Narrative
All figures RMB million, from the Five-Year Financial Summaries in the FY2020 and FY2021 Annual Reports unless noted. The last audited year is FY2021; no audited FY2022 or later accounts were found (the company was delisted before the FY2022 annual report deadline, and no subsequent publication was located).
Income statement
Notes: FY2019 cost of sales and opex from FY2020 AR MD&A; FY2021 cost of sales derived as revenue minus reported gross profit. FY2017 shows positive EPS despite a group loss, reflecting attribution to non-controlling interests (per the summary as reported). Pre-tax income by year was not separately retrieved for the five-year span.
Margins (%)
Revenue CAGR FY2017–FY2021: ~33.6% (heavily distorted by the one-off FY2020 trading spike; FY2020–FY2021 revenue fell 73.9%). FY2016 revenue was RMB 24.3 million, so revenue over FY2016–FY2021 grew only from RMB 24.3M to RMB 50.1M.
Interim results (unaudited)
Sources: 2021 Interim Report; 2022 Interim Results Announcement (26 Aug 2022). The H1 2021 loss was mainly driven by ~RMB 29.8 million of provisions on trade and other receivables (profit warning, 24 Aug 2021).
Balance sheet
Additional disclosed balance-sheet items: trade receivables RMB 61.4M net at 31 Dec 2020 (of which RMB 42.6M still unsettled at report date); inventories RMB 22.3M net of RMB 9.9M allowance at 31 Dec 2020; investment properties in Suzhou Industrial Park at fair value RMB 57.8M (2020) and RMB 56.5M (2021), pledged; gearing (bank loans plus lease liabilities ÷ total assets) 5.6% (2020) and 8.4% (2021). Distributable reserves: nil at end-2020 and end-2021 (RMB 44.4M at end-2019).
Cash flow
The FY2020 cash decline of ~RMB 166M (with revenue of only RMB 192M and a loss of RMB 57M) indicates heavy working-capital absorption — consistent with the build-up of trade receivables and inventories later impaired. The placing proceeds (HK$257.38M) were fully used by end-FY2021.
Ratios
ROIC, current ratio, interest coverage, net debt/EBITDA and cash conversion cycle: not computable from retrieved data (net debt/EBITDA is not meaningful given negative EBITDA and a net cash position).
Commentary on trends, inflections and drivers
FY2017–FY2019: a cash-rich shell with a sub-scale business. Revenue stayed between RMB 15.7M and RMB 25.8M while the December 2018 placing lifted cash to RMB 252.5M — two-thirds of total assets. Losses of RMB 52–62M a year were driven by administrative costs (RMB 36.1M in FY2019) far exceeding gross profit.
FY2020: the trading spike. Management deployed placing cash into supply-chain trading and e-tailing, multiplying revenue 7.4x to RMB 191.6M but collapsing gross margin to 11.5%. Cash fell RMB 166M. The auditor qualified its opinion because it could not obtain sufficient evidence on the recoverability of receivables from new customers with no credit history, nor on inventory realisable value. This is the critical inflection: revenue growth was bought with working capital that subsequently proved partly unrecoverable.
FY2021: unwind and impairment. Revenue fell 73.9% as supply-chain trading was cut; the trade receivables allowance jumped roughly 20-fold to RMB 19.7M and slow-moving inventory provisions lifted other operating expenses 56% to RMB 15.7M. The loss widened to RMB 96.4M and equity nearly halved to RMB 108.8M. Two loss-making subsidiaries were sold for nominal consideration.
H1 2022: revenue fell further to RMB 15.3M; the operating loss narrowed to RMB 14.5M as cost cuts took hold, but the business remained sub-scale relative to Rule 13.24 expectations.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | What it contains | Key subsidiaries / brands |
|---|---|---|
O2O commerce | Commerce solutions for authorised brands (online and offline); e-tailing of branded goods; customised supply chain management solutions | Grace Cole, Mimi Luzon, Stella McCartney (PRC franchise), Nutronic (via Smartronic until Dec 2021), Zhangzhou Keruilin (health food, from Nov 2021) |
Electronic payment solutions | WeChat Pay merchant access, settlement and marketing in Hong Kong | Haihai Limited |
Others | Social CRM platforms and IT support for PRC shopping malls, property managers, developers | Shanghai Shijiexian Network Technology (wholly owned PRC subsidiary; exact segment mapping not disclosed) |
O2O commerce | Hong Kong (physical stores, supply chain) and PRC (Tmall/JD.com stores, Stella McCartney franchise, health food, Korean cosmetics) | FY2020/FY2021 AR; 30 Dec 2022 announcement |
Electronic payment solutions | Hong Kong only | FY2021 AR |
Others (CRM/IT) | PRC only | FY2021 AR |
Region revenue (CNY Mn) | FY2019 | FY2020 |
Revenue by Segment
| Segment (CNY Mn) | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
O2O commerce revenue | 19.672 | 188.916 | 44.974 |
Electronic payment solutions revenue | 3.424 | 1.950 | 2.436 |
Others (IT/CRM) revenue | 2.701 | 0.782 | 2.673 |
Total revenue | 25.797 | 191.648 | 50.083 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Revenue by Segment (%)
| Metric (%) | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
O2O commerce YoY growth | — | 860.3 | -76.2 |
Electronic payment YoY growth | — | -43.0 | 24.9 |
Others YoY growth | — | -71.0 | 241.8 |
O2O share of revenue | 76.3 | 98.6 | 89.8 |
Electronic payment share of revenue | 13.3 | 1.0 | 4.9 |
Others share of revenue | 10.5 | 0.4 | 5.3 |
Income Statement and Per-Share Data
| Metric (CNY Mn) | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
Revenue | 15.693 | 17.356 | 25.797 | 191.648 | 50.083 |
Cost of sales | — | — | 12.182 | 169.551 | 35.188 |
Gross profit | — | — | 13.615 | 22.097 | 14.895 |
Selling expenses | — | — | 8.933 | 27.565 | 23.613 |
Administrative expenses | — | — | 36.097 | 45.084 | 44.641 |
Other operating expenses | — | — | 1.718 | 10.043 | 15.668 |
Trade receivables impairment allowance | — | — | — | 0.936 | 19.678 |
EBIT | -0.134 | -63.802 | -59.903 | -55.517 | -95.375 |
EBITDA | 14.407 | -55.222 | -50.078 | -50.330 | -89.594 |
Loss for the year (group) | -5.666 | -62.414 | -52.400 | -56.950 | -96.366 |
EPS basic (MYR Bn) | 0.0033 | -0.0117 | -0.0067 | -0.0088 | -0.0150 |
EPS diluted (MYR Bn) | 0.0033 | -0.0117 | -0.0067 | -0.0088 | -0.0150 |
Dividend per share (MYR Bn) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric (%) | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
Gross margin | — | — | 52.8 | 11.5 | 29.7 |
EBIT margin | -0.9 | -367.6 | -232.2 | -29.0 | -190.4 |
EBITDA margin | 91.8 | -318.2 | -194.1 | -26.3 | -178.9 |
Net margin | -36.1 | -359.6 | -203.1 | -29.7 | -192.4 |
Income Statement
| Metric (CNY Mn) | H1 2020 | H1 2021 | H1 2022 |
|---|---|---|---|
Revenue | 53.562 | 35.032 | 15.275 |
Loss from operations | -16.569 | -64.535 | -14.452 |
Loss before tax | -16.502 | -61.743 | -15.368 |
Loss for the period | -16.476 | -61.652 | — |
Balance Sheet and Per-Share Data
| Metric (CNY Mn) | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
Total assets | 246.080 | 377.323 | 322.433 | 255.519 | 163.734 |
Cash and equivalents incl. pledged deposits | 20.551 | 252.459 | 226.374 | 60.469 | 56.797 |
Total liabilities (derived) | 95.600 | 60.263 | 54.017 | 55.914 | 54.953 |
Net asset value (equity) | 150.480 | 317.060 | 268.416 | 199.605 | 108.781 |
Bank loans total | — | — | 9.000 | 8.000 | 10.160 |
Bank loans due within one year | — | — | 9.000 | 8.000 | 0.733 |
Bank loans due after one year | — | — | 0.000 | 0.000 | 9.427 |
Net cash (cash minus bank loans) | — | — | 217.374 | 52.469 | 46.637 |
NAV per share (MYR Bn) | 0.03 | 0.06 | 0.05 | 0.04 | 0.02 |
Ordinary shares (M) | 4,762.033 | 5,635.971 | 5,635.971 | 5,635.971 | 5,635.971 |
Balance Sheet
| Metric (CNY Mn) | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
Equity raised (placing, net) | 0 | 226.926 | 0 | 0 | 0 |
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Share buybacks | 0 | 0 | 0 | 0 | 0 |
Change in cash incl. pledged deposits | — | 231.908 | -26.085 | -165.905 | -3.672 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
ROE (%, loss ÷ closing NAV) | -3.8 | -19.7 | -19.5 | -28.5 | -88.6 |
ROA (%, loss ÷ closing assets) | -2.3 | -16.5 | -16.3 | -22.3 | -58.9 |
Asset turnover (x) | 0.06 | 0.05 | 0.08 | 0.75 | 0.31 |
Liabilities ÷ equity (x) | 0.64 | 0.19 | 0.20 | 0.28 | 0.51 |
Bank debt ÷ equity (x) | — | — | 0.03 | 0.04 | 0.09 |
Cash ÷ total assets (%) | 8.4 | 66.9 | 70.2 | 23.7 | 34.7 |
Capital Markets
| Item | Detail |
|---|---|
Listing status | Delisted from HKEX Main Board, 20 Feb 2023 |
Last trading day | 31 Mar 2021 (suspended from 1 Apr 2021) |
Valuation multiples (P/E, EV/EBITDA, EV/Sales, P/B) | Not applicable; negative earnings and EBITDA in all years FY2018–FY2021 |
Book value reference | NAV RMB 108.8M (RMB 0.02/share) at 31 Dec 2021 |
Analyst coverage / consensus | None identified |
Dividend history | No dividends for FY2019, FY2020, FY2021; distributable reserves nil at end-2020 and end-2021 |
Dividend policy | Discretionary, based on performance, liquidity, capital needs, covenants and Cayman law (FY2021 AR) |
Buybacks | None disclosed |
Equity issuance | 812.5M-share placing, Dec 2018 (net HK$257.38M); consideration shares to LCE vendor, Jun 2018 |
Credit ratings (Moody's/S&P/Fitch) | Not rated |
Debt maturity profile | Bank loans RMB 10.16M at end-2021, fixed-rate, RMB-denominated: RMB 0.73M due within one year; RMB 9.43M due after one year; secured on PRC building, Suzhou investment properties, land use rights and a personal guarantee from a subsidiary director |
Share count and capital metric | FY2017 |
Ordinary shares issued (M) | 4,762.033 |
NAV per share (MYR Bn) | 0.03 |
Dividend per share (MYR Bn) | 0 |
Analyst Conclusions
Management guidance
No quantitative guidance was ever issued. The last qualitative outlook (30 Dec 2022) expected significant revenue growth from Korean cosmetics sales through existing O2O channels, benefits from PRC reopening, and expansion into modular energy storage, supported by what management described as abundant financial resources.
Consensus
None. No sell-side coverage exists.
Bull case (grounded in disclosed data)
-
Asset backing exceeds operating value: RMB 56.8M cash plus RMB 56.5M Suzhou property against total liabilities of ~RMB 55.0M at end-2021 leaves meaningful net tangible value for a private shareholder base.
-
Revenue traction from Korean cosmetics: RMB 18.35M in just two months (Nov–Dec 2022) suggests the annualised run-rate could exceed FY2021 revenue if sustained.
-
Post-2023 border reopening: the HK WeChat Pay business was explicitly geared to the return of mainland visitors.
Bear case
-
Track record of value destruction: cumulative losses of RMB 268M over FY2018–FY2021 and equity down 66% from its FY2018 peak.
-
Credit and inventory quality: qualified audit, RMB 42.6M of unsettled FY2020 receivables, a 20-fold jump in receivables allowances in FY2021 — evidence that revenue growth was not cash-backed.
-
No public market or reporting: after delisting, minority shareholders hold unlisted Cayman shares with minimal disclosure and no liquidity; the founder owns only 10.51%, so no controlling shareholder has an obvious incentive to buy out minorities.
Catalysts and monitorables (next 12 months)
-
Any announcement of a privatisation offer, asset sale (e.g., Suzhou properties), liquidation, or relisting attempt.
-
Publication (voluntary or via the Cayman registry) of FY2022–FY2025 accounts.
-
Status of the Korean cosmetics supply agreement and energy storage venture.
-
PRC tax authority action on the LCE Group indirect transfer.
-
Whether the smartacgroup.com website and investor email remain active.
Analyst verdict
Smartac International Holdings is no longer an investable listed security, and the evidence in its own filings explains why. Across two decades the company moved from a genuinely leading niche industrial franchise — Asia Zirconium, once the PRC's largest zirconium chemicals exporter — through a succession of thinly capitalised technology and commerce ventures, none of which reached the scale or profitability needed to justify a Main Board listing. The December 2018 placing gave management roughly HK$257 million to build a durable business. Instead, the capital funded a one-year surge of low-margin supply chain trading in FY2020 that produced headline revenue of RMB 191.6 million but also a qualified audit, large unrecoverable receivables and slow-moving inventory. By FY2021 revenue had fallen back to RMB 50.1 million, losses reached RMB 96.4 million, and equity had dropped to RMB 108.8 million. The Stock Exchange's conclusion that the company did not have sufficient operations under Rule 13.24 was upheld at every level of review, and the listing was cancelled on 20 February 2023.
The residual entity still had tangible assets at its last report — net cash and pledged Suzhou investment properties — and a late burst of Korean cosmetics sales showed that its distribution channels could move product. However, without public reporting, a controlling shareholder, or a liquid market, these assets offer little practical protection to minority holders. Governance signals were consistently weak: repeated INED shortfalls, rapid executive turnover, and a pattern of strategic announcements that preceded rather than followed operating evidence.
For any counterparty, creditor or investor encountering this entity today, the appropriate stance is forensic rather than fundamental: verify current corporate existence and ownership through the Cayman registry, obtain any unpublished FY2022+ accounts directly, and treat all pre-2023 disclosures as historical. On the public record, the verdict is negative: a delisted micro-cap with an unproven business model, no market, and no disclosure.
Key sources (HKEXnews and others):
-
FY2021 Annual Report (26 Apr 2022): https://www1.hkexnews.hk/listedco/listconews/sehk/2022/0426/2022042600249.pdf
-
FY2020 Annual Report (2 Jun 2021): https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0602/2021060200859.pdf
-
Quarterly update and review request (30 Dec 2022): https://www1.hkexnews.hk/listedco/listconews/sehk/2022/1230/2022123002300.pdf
-
HKEX cancellation announcement (16 Feb 2023): https://www.hkex.com.hk/News/Regulatory-Announcements/2023/230216news?sc_lang=en
-
Company LRC decision announcement (15 Feb 2023): https://www1.hkexnews.hk/listedco/listconews/sehk/2023/0215/2023021500499.pdf
-
Suspension announcement (1 Apr 2021): https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0401/2021040100497.pdf
-
2022 Interim Results (26 Aug 2022): https://www1.hkexnews.hk/listedco/listconews/sehk/2022/0826/2022082601815.pdf
-
2021 Interim Report: https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0914/2021091400360.pdf
-
Profit warning (24 Aug 2021): https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0824/2021082401452.pdf
-
Asia Zirconium Annual Reports 2003, 2005, 2006 (HKEXnews archive)
-
China Zirconium Limited (Wikipedia): https://en.wikipedia.org/wiki/China_Zirconium_Limited
-
ACN Newswire, Smartac Q1 2020 results (15 May 2020): https://www.acnnewswire.com/press-release/english/59063/smartac's-2020-first-quarter-revenue-soars-411.6
-
HKEX Disclosure of Interests filing (June 2015): https://di.hkex.com.hk/di/NSForm3A.aspx?fn=172617
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Age (FY2021 AR) | Background / education |
|---|---|---|---|---|
Yang Xin Min | Chairman, Executive Director; founding chairman; substantial shareholder | Group GM since Aug 1977; ED re-designation Dec 2020; CEO Apr–Jul 2021 | 72 | Senior economist; 40+ years in zirconium chemicals research, production and international markets; graduate of Beijing Economics Correspondence College; formerly vice chairman of the zirconium branch of the China Nonferrous Metals industry association |
Ke Haiwei | Executive Director; Joint CEO (external operations and investment projects) | ED/Joint CEO from 1 Jul 2021; COO Jun–Jul 2021 | 46 | Founder and chairman of Xiamen Zhexin Investment and Xiamen Dingsheng Tianhe Wenhua Chuangyi since 2008; finance and corporate management experience |
Wong Wai Wai | Executive Director; Joint CEO (internal control and investment projects) | ED/Joint CEO from 1 Jul 2021; CIO Jun–Jul 2021 | 39 | VP at New China Capital Management (HK) 2006–2019; board observer/senior adviser at Centron Telecom 2009–2017; ED of Anucell Technology 2016–2020; BSc, Chinese University of Hong Kong |
Poon Lai Yin Michael | INED; chair of Audit and Remuneration Committees | Since Jan 2010 | 50 | ED and CFO of Huakang Biomedical (8622) since 2017; INED of several HK-listed companies; FCPA (HKICPA), CPA Australia; York University (BA), Monash (MPA) |
Wang Haoxian | INED; chair of Nomination Committee | Since 30 Sep 2021 | 41 | Partner, Shenzhen Anpingtai Enterprise Management Consulting (since 2015); accounting degree, Jiangxi University of Finance and Economics |
Leung Kwong Choi | INED | — | — | — |
Hung Ee Tek | CFO and Company Secretary | Since Jul 2021 | 59 | HKICPA and ACCA member; MA International Accounting (CityU HK); MA Global China Studies (HKUST); INED of Xinjiang Tianye Water Saving Irrigation (840) |
Board & Management Changes
| Date | Change |
|---|---|
23 Apr 2021 | CEO Ho Chi Kin ("Jeff Ho") resigned; Yang Xin Min became Chairman and CEO (deviation from CG Code on role separation) |
29 Apr 2021 | INEDs Tsui Francis King Chung and Tang Yat Ming Edward resigned |
30 Jun 2021 | INED Peng Bobo retired (board fell below the INED minimum until 30 Sep 2021) |
1 Jul 2021 | Ke Haiwei and Wong Wai Wai appointed Joint CEOs; role separation restored |
8 Jul 2021 | Company secretary/CFO Yeung Wai Ling replaced by Hung Ee Tek |
30 Sep 2021 | Wang Haoxian appointed INED |
31 Dec 2021 | INED Dr. Cheng Faat Ting Gary resigned after 20 years (INED count again below Rule 3.10(1) minimum) |
| 2022 | Leung Kwong Choi appointed INED (board of six by Dec 2022) |
Major Shareholders
| Holder | Shares | % of issued | Source |
|---|---|---|---|
Yang Xin Min (beneficial) | 592,573,880 | 10.51 | FY2021 AR |
Ke Haiwei | 30,328,000 | 0.54 | FY2021 AR |
Wang Haoxian | 9,504,000 | 0.16 | FY2021 AR |
Wong Wai Wai | 1,960,000 | 0.03 | FY2021 AR |
Other 5%+ holders | None disclosed | — | FY2021 AR |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors | Relative positioning |
|---|---|---|
Brand e-commerce partner / TP (PRC) | Baozun (NASDAQ: BZUN; HKEX: 9991); Ruoyuchen Technology (SZSE: 003010); Lily & Beauty (SSE: 605136); Yunji (NASDAQ: YJ) | Large-scale operators with hundreds of brand clients; Smartac had a handful of brands |
Beauty / wellness retail (HK) | Sa Sa International (HKEX: 178); Bonjour Holdings (historic); A.S. Watson's Watsons and Mannings (Dairy Farm) | Dominant HK chains; Smartac operated five stores at peak |
Health supplements distribution (PRC/HK) | By-health (SZSE: 300146); Huakang Biomedical (HKEX: 8622, former partner) | Smartac exited this niche in Dec 2021 |
WeChat Pay / mobile acquiring (HK) | KPay; Yedpay; AsiaPay; Global Payments; Octopus merchant services | Small reseller among many acquirers |
Mall CRM / digital marketing SaaS (PRC) | Mallcoo (猫酷); Tencent smart retail tools; Alibaba Intime/ecosystem tools | Legacy niche, RMB 2.7M revenue in FY2021 |
Competitor Detail
| Metric | Smartac (FY2021) |
|---|---|
Revenue | RMB 50.1M |
Revenue growth | -73.9% |
Gross margin | 29.7% |
Net margin | -192.4% |
Recent Developments
After the 20 February 2023 delisting, the company ceased to be subject to HKEX disclosure obligations, and no subsequent press releases, filings or media coverage were located.



